Praxis Precision Medicines (PRAX) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | 459.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 459.41% |
| Dec 31, 2025 | 344.72% |
| Sep 30, 2025 | -133.56% |
| Jun 30, 2025 | -19.23% |
| Mar 31, 2025 | -170.47% |
| Dec 31, 2024 | 336.17% |
| Sep 30, 2024 | 201.24% |
| Jun 30, 2024 | -115.73% |
| Mar 31, 2024 | 267.67% |
| Dec 31, 2023 | -2,298.18% |
| Sep 30, 2023 | -462.68% |
| Jun 30, 2023 | 299.23% |
| Mar 31, 2023 | 131.28% |
| Dec 31, 2022 | 96.94% |
| Sep 30, 2022 | 162.75% |
| Jun 30, 2022 | -148.32% |
| Mar 31, 2022 | 62.86% |
| Dec 31, 2021 | -114.83% |
| Sep 30, 2021 | -110.73% |
| Jun 30, 2021 | 234.34% |
| Mar 31, 2021 | -328.99% |
| Dec 31, 2020 | 349.03% |